Eluting characteristics of a platelet glycoprotein receptor antibody using a PLLA-coated stent.

about

Endothelialization and in-stent restenosis on the surface of glycoprotein IIIa monoclonal antibody eluting stent.

P2860

Q34177967-6AFF5C9C-ED6F-41C8-905D-695B12B1691C

P2860

Eluting characteristics of a platelet glycoprotein receptor antibody using a PLLA-coated stent.

Item

http://www.wikidata.org/entity/Q47862043

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Eluting characteristics of a p ...... ody using a PLLA-coated stent.

@en

Eluting characteristics of a p ...... ody using a PLLA-coated stent.

@nl

type

Item

label

Eluting characteristics of a p ...... ody using a PLLA-coated stent.

@en

Eluting characteristics of a p ...... ody using a PLLA-coated stent.

@nl

prefLabel

Eluting characteristics of a p ...... ody using a PLLA-coated stent.

@en

Eluting characteristics of a p ...... ody using a PLLA-coated stent.

@nl

P1476

Eluting characteristics of a p ...... body using a PLLA-coated stent

@en

P2093

C-G Ruan

http://www.w3.org/2001/XMLSchema#string

G-X Wang

http://www.w3.org/2001/XMLSchema#string

L-L Luo

http://www.w3.org/2001/XMLSchema#string

R Guidoin

http://www.w3.org/2001/XMLSchema#string

T-Y Yin

http://www.w3.org/2001/XMLSchema#string

Y-B Hou

http://www.w3.org/2001/XMLSchema#string

Y-Z Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty

Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril

Solubilization of rapamycin.

The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro.

Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells.

Rapamycin inhibits vascular smooth muscle cell migration.

Important triad in cardiovascular medicine: diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa receptor blockade.

New frontiers in cardiology: drug-eluting stents: Part I.

The long-term clinical results of a platelet glycoprotein IIb/IIIa receptor blocker (Abciximab: Reopro) coated stent in patients with coronary artery disease.

P304

359-371

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1163/156856208783721001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Randolph P Guzman

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5527589

http://www.w3.org/2001/XMLSchema#string

P698

18325236

http://www.w3.org/2001/XMLSchema#string

Eluting characteristics of a platelet glycoprotein receptor antibody using a PLLA-coated stent.

about

P2860

P2860

Eluting characteristics of a platelet glycoprotein receptor antibody using a PLLA-coated stent.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698